Article

McKesson to Pay $190 Million to Resolve False-Claims Allegations

In a news release, the U.S. Justice Department said that states can separately negotiate resolutions with McKesson pertaining to claims based on the states' shares of Medicaid overpayments.

Story in progress.

Read this story: http://hcp.lv/KdT9b1

Source: ModernHealthcare.com

McKesson Corp., a San Francisco-based drug wholesaler and health information technology provider, will pay the U.S. more than $190 million to resolve claims it reported inflated prices for several prescription drugs, causing Medicaid to overpay for the drugs.

Related Videos
Ibrahim Aldoss, MD, associate professor, City of Hope
Dr CK Wang
James Chalmers, MD
Vincent Picozzi, MD, medical oncologist and director of the pancreaticobiliary program, Virginia Mason
Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida
1 expert is featured in this series.
Ali Khawar
Priscilla Tsondai, MD, MPH, International AIDS Society/CIPHER
Eileen Peng, PharmD, sitting for a video interview
Related Content
Cancer cell screening and detection | Image credit: freshidea - stock.adobe.com
June 1st 2025

Multicancer Detection Assays Remain Largely Elusive for Early-Stage Disease Detection

Silas Inman
Multicancer early detection tests are revolutionizing cancer screening by using liquid biopsies to screen for multiple cancers from a single blood sample, enhancing patient outcomes by identifying cancers earlier.
managed care cast logo
May 29th 2025

Laundromats as a New Frontier in Community Health, Medicaid Outreach

Brooke McCormick Lindsey Jeanne Leininger, PhD Allister Chang, MPA
Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Lung cancer illustration | Image credit: SciePro - stock.adobe.com
May 31st 2025

Assay Finds Patients Who Will Benefit From Adjuvant Chemotherapy in Early-Stage NSCLC

Mary Caffrey
Today, cancer stage and tumor size tell which patients will receive adjuvant chemotherapy. But the rise of biomarker testing and artificial intelligence could offer new tools for assessing risk.
Managed Care Cast
May 27th 2025

Frameworks for Advancing Health Equity: Social Work and Complex Care Navigation

Giuliana Grossi Victor Murray, MSW
Victor Murray, MSW, of the Camden Coalition, delves into the evolving role of social workers, focusing on advocacy, systems change, and addressing health disparities in underserved communities.
Through data from genome-wide association studies, the researchers identified several single nucleotide polymorphisms contributing to the causal relationship between insomnia and atopic dermatitis. | Image credit: amenic181 - stock.adobe.com
May 31st 2025

Study Explores Link Between Insomnia, Atopic Dermatitis

AJMC Contributor
Researchers found a causal association between insomnia and atopic dermatitis and identified several genetic variations contributing to the association.
Inflation Reduction Act | Image Credit: wladimir1804-stock.adobe.com
May 31st 2025

Community Oncology Bracing for IRA Impact

Maggie L. Shaw
Community oncology faces significant challenges from the Inflation Reduction Act's (IRA) drug pricing changes, risking financial stability and patient access to care.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo